Year: 2012
Type: editorial
Abstract: License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Diabetes is a major cause of death in many countries due to its increasing incidence, high prevalence, and clinical manifestation of a variety of micro- and macrovascular complications if it is not appropriately treated [1, 2]. Recent studies have shown that diabetic patients may also have a higher risk of cancer [2], the number one killer that threatens the lives of billions of people. The clarification of the link between these two important diseases, new developments in clinical technologies and medications for the management and improvement of the survival of cancer patients in diabetic and nondiabetic individuals, and the understanding of the basic mechanisms of cancer and diabetes and their interrelationships are
Source: Experimental Diabetes Research
DOI: 10.1155/2012/101802
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W2038296383